Using exercise to lower heart disease risk in men receiving hormone therapy for prostate cancer
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk in Men Undergoing Androgen Deprivation Therapy
This study is looking at how exercise can help men with prostate cancer who are receiving hormone therapy stay healthier and lower their chances of heart problems, by testing easy home workout programs that can improve their fitness and heart health.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10913604 on NIH RePORTER |
What this research studies
This research focuses on how exercise can help men undergoing androgen deprivation therapy for prostate cancer reduce their risk of cardiovascular disease. It aims to evaluate the effectiveness of home-based exercise programs in improving physical fitness and overall health. By using advanced imaging techniques, the study will assess how these exercise interventions can positively impact heart health and physical function. The goal is to provide tailored exercise recommendations that can be easily accessed by patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are men aged 65 and older who are currently receiving androgen deprivation therapy for prostate cancer.
Not a fit: Patients who are not undergoing androgen deprivation therapy or are younger than 65 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help men undergoing hormone therapy for prostate cancer improve their heart health and quality of life through effective exercise programs.
How similar studies have performed: Previous research has shown that exercise training can effectively mitigate treatment side effects in cancer patients, suggesting a promising approach in this area.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Lucas, Alexander Russell — Virginia Commonwealth University
- Study coordinator: Lucas, Alexander Russell
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.